The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Author(Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Sarafidis, K., Chatziioannou A. Chrysovala, Thomaidou A., Gika H., Mikros E., Benaki D., et al. (2017).  Urine metabolomics in neonates with late-onset sepsis in a case-control study.. Sci Rep. 7, 45506.
Sarafidis, P. A., Stafylas P. C., Georgianos P. I., Saratzis A. N., & Lasaridis A. N. (2010).  Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis.. Am J Kidney Dis. 55(5), 835-47.
Sarafidis, P. A., Theodorakopoulou M., Dipla K., Zafeiridis A., Boutou A., Loutradis C., et al. (2020).  Hyponatremia accompanying volatile hypertension caused by baroreflex failure after neck surgery: case report and literature review.. J Hypertens. 38(8), 1617-1624.
Sarafidis, P. A., Georgianos P. I., Malindretos P., & Liakopoulos V. (2012).  Pharmacological management of hypertensive emergencies and urgencies: focus on newer agents.. Expert Opin Investig Drugs. 21(8), 1089-106.
Sarafidis, P. A., Loutradis C., Mayer C. C., Karpetas A., Pagkopoulou E., Bikos A., et al. (2019).  Weak within-individual association of blood pressure and pulse wave velocity in hemodialysis is related to adverse outcomes.. J Hypertens. 37(11), 2200-2208.
Sarafidis, P., Ferro C. J., Morales E., Ortiz A., Malyszko J., Hojs R., et al. (2019).  SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.. Nephrol Dial Transplant. 34(2), 208-230.
Sarafidis, P., Bowes E., Rumjon A., Ansari B., & Cairns H. (2013).  A novel technique for repositioning, under local anesthetic, malfunctioning and migrated peritoneal dialysis catheters.. Perit Dial Int. 33(6), 700-4.
Sarafidis, P. A., & Ruilope L. M. (2014).  The authors reply.. Kidney Int. 86(4), 855.
Sarafidis, P. A. (2015).  Patient Cases: 1. A Patient with Apparent Compliance.. High Blood Press Cardiovasc Prev. 22 Suppl 1, S15-8.
Sarafidis, P., Ferro C. J., Morales E., Ortiz A., Malyszko J., Hojs R., et al. (2020).  Erratum.. Nephrol Dial Transplant. 35(8), 1452.
Sarafidis, P. A., & Ruilope L. M. (2014).  Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation?. Kidney Int. 85(3), 536-46.
Sarafidis, P. A., Loutradis C., Karpetas A., Tzanis G., Bikos A., Raptis V., et al. (2020).  The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients.. Nephrol Dial Transplant. 35(7), 1277.
Sarafidis, P. A., Stavridis K. C., Loutradis C. N., Saratzis A. N., Pateinakis P., Papagianni A., et al. (2016).  To intervene or not? A man with multidrug-resistant hypertension, endovascular abdominal aneurysm repair, bilateral renal artery stenosis and end-stage renal disease salvaged with renal artery stenting.. Blood Press. 25(2), 123-8.
Sarafidis, P., Faitatzidou D., & Papagianni A. (2020).  Benefits and risks of frequent or longer haemodialysis: weighing the evidence.. Nephrol Dial Transplant.
Sarafidis, P. A., & Bakris G. L. (2015).  Cardiovascular disease in CKD in 2014: new insights into cardiovascular risk factors and outcomes.. Nat Rev Nephrol. 11(2), 70-2.
Sarafidis, P. A., Persu A., Agarwal, iv R., Burnier M., de Leeuw P., Ferro C., et al. (2017).  Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kid. J Hypertens. 35(4), 657-676.
Sarafidis, P. A., & Bakris G. L. (2014).  Renin inhibition in patients with chronic kidney disease: is it conclusively non-indicated?. J Renin Angiotensin Aldosterone Syst. 15(1), 97-8.
Sapountzis, S., Kiranantawat K., Foroglou P., Chantes A., Antoniou A., Dionyssiou D., et al. (2013).  Correction of Severe "Pixie Ear" Deformity after Rhytidectomy with Modified Minimal Access Cranial Suspension Lift. Archives of Plastic Surgery. 40(6), 797.
Sapountzis, S., Kiranantawat K., Foroglou P., Chantes A., Antoniou A., Dionyssiou D., et al. (2013).  Correction of severe "pixie ear" deformity after rhytidectomy with modified minimal access cranial suspension lift.. Arch Plast Surg. 40(6), 797-9.
Sapalidis, K., Machairiotis N., Zarogoulidis P., Vasilakaki S., Sardeli C., Koimtzis G., et al. (2019).  Genes' Interactions: A Major Contributor to the Malignant Transformation of Endometriosis.. Int J Mol Sci. 20(8), 
Sapalidis, K., Schizas N., Lazopoulos A., Kamparoudi P., Paliouras D., Sardeli C., et al. (2018).  Multiple metachronous and synchronous malignancies with lung and thorax involvement. Report of two cases.. Respir Med Case Rep. 24, 5-7.
Sapalidis, K., Strati T. Marina, Liavas L., Kotidis E., Koletsa T., Tsiompanou F., et al. (2016).  Heterotopic mesenteric ossification of ileostomy - "intraabdominal myositis ossificans".. Rom J Morphol Embryol. 57(1), 277-81.
Sapalidis, K., Zarogoulidis P., Petridis D., Kosmidis C., Fyntanidou B., Tsakiridis K., et al. (2019).  EBUS-TNBA 22G samples: Comparison of PD-L1 expression between DAKO and BIOCARE.. J Cancer. 10(20), 4739-4746.
Sapalidis, K., Laskou S., Amaniti A., Koulouris C., Giannakidis D., Mantalovas S., et al. (2018).  New hybrid method for trachea dilatation with rigid and flexible tools.. Respir Med Case Rep. 24, 65-73.
Sapalidis, K., Papanastasiou A., Michalopoulos N., Mantalovas S., Giannakidis D., Koimtzis G. D., et al. (2019).  A Rare Coexistence of Medullary Thyroid Cancer with Graves Disease: A Case Report and Systematic Review of the Literature.. Am J Case Rep. 20, 1398-1401.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.